PEN in “Managed Care's Margin Machine Breaks”
Penumbra, Inc.
Higher access to thrombectomy and vascular interventions supports utilization of its neurovascular and peripheral clot-removal products.
PEN impact map — “Managed Care's Margin Machine Breaks”
How this story travels from the headline to PEN’s own business — positive, negative or mixed, direct or indirect, the mechanism, and how strong the exposure is.
Loading PEN impact map…
Price history, marked with story events
Aug 25, 2025 – Aug 26, 2026 · 253 sessions
Prices updated during market hours · refreshed about every 30 minutes while the market is open · delayed data, not for trading decisions
Numbered markers tie price moves to earnings, trial or study results, management comments and analyst or demand data. Loading events…
Full story
Managed Care's Margin Machine Breaks
Rising utilization, tougher reimbursement and scrutiny of denials are shifting economics from insurers back to care providers.
BULL side — Higher access to thrombectomy and vascular interventions supports utilization of its neurovascular and peripheral clot-removal products.
Read the full Managed Care's Margin Machine Breaks story